Skip to main content
Clinical Trials/NCT02445885
NCT02445885
Recruiting
Not Applicable

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Thomas Engstrom1 site in 1 country150 target enrollmentMay 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Heart Disease
Sponsor
Thomas Engstrom
Enrollment
150
Locations
1
Primary Endpoint
Acute salvage index evaluated by MRI
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation.

This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

Detailed Description

The recommended therapy for patients with ST-segment elevation myocardial infarction (STEMI) is to restore normal coronary blood flow with timely reperfusion by percutaneous coronary intervention (PCI), and thereby minimize the extent of cell death and preserving cardiac function. The duration of ischemia and timely PCI are major determinants for the size of the myocardial infarction and prognosis. Thus, acute PCI should be performed within 12 hours after symptom onset. The effect of PCI and timing of PCI are, however, much more uncertain for late presenters who contact the health service \> 12 hours from symptom. Thus, it is still unknown whether late presenters should be treated with acute PCI or medical treatment with delayed PCI (24-72 h after first medical contact). The study investigates the effect on final salvage index evaluated by magnetic resonance imaging of acute PCI of late presenters. The overall objective of the study is to investigate whether late presenters may benefit from acute PCI, and thus whether to extend the currently recommended time limit of 12 hours for acute PCI in patients with STEMI.

Registry
clinicaltrials.gov
Start Date
May 2015
End Date
March 1, 2039
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Thomas Engstrom
Responsible Party
Sponsor Investigator
Principal Investigator

Thomas Engstrom

Chief Consultant

Rigshospitalet, Denmark

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria:
  • Patients more than 18 years of age.
  • STEMI \> 12 hours and \< 36 hours.
  • Clinical stable, i.e. no on going angina, hemodynamically stable (systolic BP \> 90) and Killip class \< 3.

Exclusion Criteria

  • Clinical instability which requires an acute invasive strategy.
  • Left main occlusion or multivessel disease which requires CABG.
  • Previous Q-wave infarction in the current infarct related artery.
  • Left Bundle Branch Block (LBBB).
  • Severe renal insufficiency.
  • Pacemaker
  • Chronic atrial fibrillation.
  • Previous Coronary Artery Bypass Surgery (CABG).
  • Pregnancy.
  • Other severe illness with life expectancy less than 1 year

Outcomes

Primary Outcomes

Acute salvage index evaluated by MRI

Time Frame: 1-2 days

MRI within 48 timer after index admission will be used to measure are at risk (AAR, T2-weighted) and acute infarct size (IZ). Acute salvage index is (AAR-IZ)/AAR

Secondary Outcomes

  • Final infarct size(3 months)
  • Microvascular obstruction (MVO)(1-2 days)
  • Final myocardial salvage index(1-2 days)
  • Left Ventricular Ejection Fraction (LVEF)(1-2 days and 3 months)
  • Acute infarct size(1-2 days)

Study Sites (1)

Loading locations...

Similar Trials